About Vankem Formulation Private Limited
Data last updated:
Vankem Formulation Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74900UP2010PTC041015. Its GSTIN is 09AADCV3522C1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹1.1 Lakh and a paid-up capital of ₹1.1 Lakh. It was formerly known as Vankem Formulation and Marketing Private Limited. It is led by directors Vandana Singh and Arun Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3/9 Allapur Allahabad Sadar, Uttar Pradesh, India – 229411.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.79 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹3,975 (net margin 0.1%) and EBITDA of ₹3,975 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vankem.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address3/9 Allapur Allahabad Sadar, Uttar Pradesh, India – 229411
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vankem Formulation Private Limited
The main business activity of Vankem Formulation is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vankem Formulation Private Limited FY 2025 filings available
Vankem Formulation Private Limited reported revenue of ₹49.79 Lakh (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vankem Formulation Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 4% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vankem Formulation Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3,975 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,975 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vankem Formulation Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vankem Formulation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vankem Formulation Private Limited
Vankem Formulation Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ccpi Pharmachem Private Limited | ₹50.13 Lakh (FY 2024) | •••• | •••• | 540.0% | •••• | Pune, Maharashtra, India |
| Marigold Bioextracts Private Limited | ₹50.02 Lakh (FY 2016) | •••• | •••• | 275.0% | •••• | Warangal, Telangana, India |
| Indiclara Healthcare Private Limited | ₹49.98 Lakh (FY 2024) | •••• | •••• | 579.0% | •••• | Pune, Maharashtra, India |
| Ramadeus Healthcare Technology (OPC) Private Limited | ₹49.96 Lakh (FY 2025) | •••• | •••• | 105.0% | •••• | Vihar School, Thane, Maharashtra, India |
| Haoma Health Care Private Limited | ₹49.89 Lakh (FY 2025) | •••• | •••• | 106.0% | •••• | Ernakulam, Kerala, India |
| Vankem Formulation Private Limited this company | ₹49.79 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Allahabad, Uttar Pradesh, India |
| Phytomyco Research Private Limited | ₹49.78 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Mysore, Karnataka, India |
| Pan-Horus Health Care Private Limited | ₹49.77 Lakh (FY 2021) | •••• | •••• | -36.0% | •••• | Bangalore, Karnataka, India |
| Biswas Good Health Capsule Private Limited | ₹49.72 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Haryana Formulations Private Limited | ₹49.63 Lakh (FY 2022) | •••• | •••• | 16.0% | •••• | Ludhiana, Punjab, India |
| Bonum Medelae Private Limited | ₹49.62 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Ambala Cantt, Haryana, India |
Peers are the five companies nearest above and the five nearest below Vankem Formulation by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vankem Formulation Private Limited
Vankem Formulation Private Limited is audited by RAVI KUMAR SRIVASTAVA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAVI KUMAR SRIVASTAVA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vankem Formulation Private Limited
Vankem Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Singh Also directs: Vartikem Pharma Private Limited | Director | 15 Jun 2010 | 16 Years 3 Months | Current |
| Arun Kumar Singh Also directs: Vartikem Pharma Private Limited | Director | 15 Jun 2010 | 16 Years 3 Months | Current |
Ownership and Shareholding of Vankem Formulation Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vankem Formulation Private Limited
Vankem Formulation Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vankem Formulation Private Limited
Employment history and EPFO contributions of people linked to Vankem Formulation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vankem Formulation Private Limited
Vankem Formulation Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Jaiprakash Singh ceased to be Director on 08 Nov 2024.
Credit Ratings, Litigation & Regulatory Alerts for Vankem Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vankem Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vankem Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vankem Formulation Private Limited
Vankem Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCV3522C1ZN | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vankem Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vankem Formulation Private Limited
Vankem Formulation is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 2010 (16+ years old) and is registered under CIN U74900UP2010PTC041015.
Vankem Formulation reported revenue of ₹49.79 Lakh for FY 2024 (up 4% YoY).
Vankem Formulation has 2 current directors:
- Vandana Singh - Director
- Arun Kumar Singh - Director
Vankem Formulation reported a net profit of ₹3,975 (net margin 0.1%) and EBITDA of ₹3,975 (EBITDA margin 0.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vankem Formulation is 10% over three years and 14% over five years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vankem Formulation is 09AADCV3522C1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vankem Formulation is U74900UP2010PTC041015. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vankem Formulation was incorporated on 15 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Vankem Formulation by revenue are Ccpi Pharmachem Private Limited, Marigold Bioextracts Private Limited, Indiclara Healthcare Private Limited, Ramadeus Healthcare Technology (OPC) Private Limited, Haoma Health Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Jaiprakash Singh ceased to be Director on 08 Nov 2024. Praveen Kumar Tiwari ceased to be Director on 11 Sep 2019. Arun Kumar Singh was appointed as Director on 15 Jun 2010. Vankem Formulation has 4 board changes on record in total.
Vankem Formulation can be reached through the website vankem.in. Its registered office is in Allahabad, Uttar Pradesh, India.